Phibro Animal Health
PAHC
#5500
Rank
HK$11.32 B
Marketcap
HK$279.03
Share price
1.86%
Change (1 day)
-17.37%
Change (1 year)

P/E ratio for Phibro Animal Health (PAHC)

P/E ratio as of November 2026 (TTM): 14.0

According to Phibro Animal Health 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 14.0039. At the end of 2022 the company had a P/E ratio of 14.9.

P/E ratio history for Phibro Animal Health from 2014 to 2023

PE ratio at the end of each year

Year P/E ratio Change
202214.9-4.41%
202115.6-12.51%
202017.8-32.55%
201926.448.67%
201817.8-17.26%
201721.510.67%
201619.425.58%
201515.5-70.62%
201452.6

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Eli Lilly
LLY
44.8 219.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Archer Daniels Midland (ADM)
ADM
13.2-5.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Zoetis
ZTS
14.5 3.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
139 890.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Kindred Biosciences
KIN
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Heska Corporation
HSKA
-62.2-543.95%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.